In Utero Oxcarbazepine Exposure and Neonatal Abstinence Syndrome: Case Report and Brief Review of the Literature

Oxcarbazepine is a second‐generation antiepileptic drug that is used to treat partial seizures. Although it has been increasingly used in pregnant women, its fetal safety has not been fully validated. We describe a 12‐hour‐old neonate who developed neonatal abstinence syndrome (NAS) after intrauteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao‐yang, Li, Xing, Ma, Ling‐yue, Wu, Peng‐hui, Zhou, Ying, Feng, Qi, Cui, Yi‐min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575550/
https://www.ncbi.nlm.nih.gov/pubmed/28543284
http://dx.doi.org/10.1002/phar.1955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575550/
https://www.ncbi.nlm.nih.gov/pubmed/28543284
http://dx.doi.org/10.1002/phar.1955

Ejemplares similares